Cargando…
Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”
Autores principales: | Ji, Long-Shan, Gao, Qiu-Tian, Guo, Ruo-Wen, Zhang, Xin, Zhou, Zhen-Hua, Yu, Zhuo, Zhu, XiaoJun, Gao, Ya-Ting, Sun, Xue-Hua, Gao, Yue-Qiu, Li, Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808215/ https://www.ncbi.nlm.nih.gov/pubmed/35127955 http://dx.doi.org/10.1155/2022/7931597 |
Ejemplares similares
-
Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients
por: Ji, Long-Shan, et al.
Publicado: (2019) -
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Zhang, Jing-Hao, et al.
Publicado: (2022) -
Corrigendum: Efficacy of Real world Entecavir Therapy in Treatment NaïveChronic Hepatitis B Patients
Publicado: (2017) -
Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Zhu, Xiao-Jun, et al.
Publicado: (2013) -
Corrigendum to “Excretory Function of Intestinal Tract Enhanced in Kidney Impaired Rats Caused by Adenine”
por: Yun, Yu, et al.
Publicado: (2020)